A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease

Evaluate the effects of GED-0301 on mucosal intestinal tissue healing in patients with moderate to severe Crohn’s disease.

https://clinicaltrials.gov/ct2/show/NCT02367183?term=A+Randomized%2C+Double-blind%2C+Multicenter+Study+to+Explore+the+Effect+of+GED-0301+on+Endoscopic+and+Clinical+Outcomes+in+Subjects+with+Active+Crohn%E2%80%99s+Disease&rank=1

Sponsor: Celgene

Keywords: "GI", Crohn’s Disease, Crohn’s; "CD"; gastrointestinal, "IBD", inflammatory bowel disease

GED-0301-CD-001
Gastrointestinal (GI)
Kevin Casey, MD
Closed
Center for Clinical Research
585.922.3536